Research topics of the group: multiomics using patients’ samples and functional studies using in vitro models aimed at identifying the mechanisms of pathogenesis and progression of T-cell acute lymphoblastic leukemia (T-ALL), in particular to identify features with prognostic and therapeutic potential; the ultimate goal is the development of personalized medicine in T-ALL
Group composition:
1. Monika Drobna-Śledzińska, PhD (post-doc)
2. dr hab. n. med. Małgorzata Dawidowska (group leader)
3. Maria Kosmalska (biologist)
4. Natalia Maćkowska-Maślak (PhD student)